V Wealth Advisors’s GenMark Diagnostics, Inc GNMK Stock Holding History

V Wealth Advisors’s Portfolio GNMK Stock Details GNMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-300	Closed	-$4K	–	771
2017 Q2	$4K	Buy	+300	New	+$3.83K	﹤0.01%	694

Other funds holding GNMK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

V Wealth Advisors's GNMK Position: Q3 2017 in Review

V Wealth Advisors sold out of GenMark Diagnostics, Inc (GNMK) in Q3 2017, closing a stake of 300 shares — an estimated $4K sold.

V Wealth Advisors first reported a position in GNMK in Q2 2017 and held it in 1 quarter. The position peaked at $4K in Q2 2017. 96 funds tracked by Wall St. Rank hold GNMK as of Q3 2017.

V Wealth Advisors reported no remaining GenMark Diagnostics, Inc position as of Q3 2017 after selling out during the quarter.
V Wealth Advisors sold 300 GenMark Diagnostics, Inc shares in Q3 2017, an estimated $4K.
V Wealth Advisors first reported a position in GenMark Diagnostics, Inc in Q2 2017 and held it in 1 quarter.
V Wealth Advisors's GenMark Diagnostics, Inc position peaked at $4K in Q2 2017.
96 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q3 2017.

Based on V Wealth Advisors's 13F filing for Q3 2017, filed 12 Oct 2017.